Dr. Ady's research centers around surgical approaches to treat rare tumors, specifically leiomyosarcoma, which affects the inferior vena cava, a major vein in the abdomen. His studies highlight how surgeons can successfully remove significant tumors that invade major blood vessels and reconstruct those vessels to restore proper blood flow. This research is vital for developing techniques that can improve survival outcomes and quality of life for patients with similar rare conditions.
Key findings
Successfully managed a patient with inferior vena cava leiomyosarcoma by performing a combined reconstruction of the inferior vena cava and aorta, demonstrating the feasibility of complex vascular surgery.
Utilized a temporary bypass circuit during surgery to maintain blood flow, ensuring the patient remained cancer-free and had functioning grafts one year post-operation.
Showed that coordinated surgical teamwork is essential for performing intricate reconstructions when dealing with advanced cancer that affects major blood vessels.
Frequently asked questions
Does Dr. Ady study rare cancers?
Yes, Dr. Ady focuses on rare cancers such as leiomyosarcoma that affect major blood vessels.
What treatments has Dr. Ady researched?
He has researched surgical techniques for removing tumors from the inferior vena cava and aorta, including the use of bypass circuits during complex surgeries.
Is Dr. Ady's work relevant to patients with vascular tumors?
Yes, his work is highly relevant as it offers innovative solutions for patients facing similar rare vascular tumors.
Publications in plain English
The Therapeutic Benefits of Outdoor Experiences in India.
2025
Behavioral sciences (Basel, Switzerland)
Mitra SJ, Sharma-Brymer V, Mitten D, Ady J
Plain English This study looked at how spending time outdoors can help people feel better emotionally and socially in India. Researchers talked to 24 outdoor practitioners and found that nature plays a big role in regulating emotions, fostering connections with others, and healing cultural identities. The experiences created spaces for reflection and growth, and emphasized the importance of cultural ties and respecting local traditions.
Who this helps: This benefits patients seeking emotional and social healing, as well as outdoor educators and therapists looking for effective methods.
Simultaneous hybrid repair of symptomatic femoral, iliac, and abdominal aortic aneurysms.
2024
Vascular
Kennedy RE, Hamilton CA, Rahimi SA, Ady JW
Plain English This study looked at a 65-year-old man who had two types of aneurysms: a common femoral artery aneurysm and an abdominal aortic aneurysm. Instead of doing surgeries separately, doctors successfully fixed both aneurysms at the same time using a combination of traditional and modern surgical techniques. This approach not only made the surgery possible but also resulted in good recovery for the patient, showing that simultaneous treatment can be effective for patients with multiple aneurysms.
Who this helps: This helps patients with multiple aneurysms needing surgical repair.
Area Deprivation Index is not predictive of worse outcomes after open lower extremity revascularization.
2023
Journal of vascular surgery
Palte NK, Adler LSF, Ady JW, Truong H, Rahimi SA +1 more
Plain English This study examined whether a person's socioeconomic status and insurance type affect the outcomes after a surgery called open lower extremity revascularization, which improves blood flow in the legs. Researchers found that socioeconomic status, measured by the Area Deprivation Index, did not impact the risk of dying, experiencing major limb complications, or how long patients stayed in the hospital. However, uninsured patients were more likely to die after the procedure compared to those with insurance.
Who this helps: This information benefits doctors and healthcare providers by highlighting the risks faced by uninsured patients.
Modern mortality risk stratification scores accurately and equally predict real-world postoperative mortality after ruptured abdominal aortic aneurysm.
2021
Journal of vascular surgery
Ciaramella MA, Ventarola D, Ady J, Rahimi S, Beckerman WE
Plain English This study looked at three scoring systems used to predict the chances of survival after surgery for patients with a ruptured abdominal aortic aneurysm (rAAA). Researchers found that out of 49 patients who had surgery, 37% died in the hospital, with a higher risk (63%) for those who had open surgery compared to those who had endovascular repair (24%). These findings are important because they show that the HMC, VSGNE, and DAS scores are equally effective at estimating mortality risk, helping doctors make better decisions about treatment options before surgery.
Who this helps: This helps doctors and patients involved in rAAA surgeries.
Concomitant Aorto-Caval Reconstruction for Inferior Vena Cava Leiomyosarcoma.
2021
Annals of vascular surgery
Grieff AN, Hamilton C, Ady J, Beckerman WE, Shafritz R +2 more
Plain English Doctors treated a 63-year-old man with a rare cancer (leiomyosarcoma) that started in a major vein in his abdomen and had unexpectedly grown into his aorta (the largest artery). They removed the entire tumor and surgically rebuilt both the vein and artery using grafts, using a special bypass technique to keep blood flowing during surgery.
The patient recovered well and remained cancer-free a year later with both grafts working properly. This case shows that when this rare cancer involves both the vein and artery, surgeons can successfully remove it and rebuild both vessels if the patient is healthy enough to handle the complex operation.
Hiking: A Low-Cost, Accessible Intervention to Promote Health Benefits.
2018
American journal of lifestyle medicine
Mitten D, Overholt JR, Haynes FI, D'Amore CC, Ady JC
Plain English The study examined how hiking can help people increase their physical activity levels and improve their health. Researchers found that hiking leads to immediate benefits like lower blood pressure and stress levels, as well as long-term advantages such as weight loss and decreased depression. This matters because promoting hiking as an easy and affordable activity can help people adopt healthier lifestyles and improve their overall wellness.
Who this helps: This helps patients looking for accessible ways to stay active and improve their health.
Tunneling nanotubes: an alternate route for propagation of the bystander effect following oncolytic viral infection.
2016
Molecular therapy oncolytics
Ady J, Thayanithy V, Mojica K, Wong P, Carson J +3 more
Plain English This research studied how tiny connections between cells, called tunneling nanotubes, can help spread a cancer-fighting virus from infected cells to nearby uninfected cells. The researchers found that these nanotubes not only allowed the transfer of a fluorescent protein from one cell to another but also facilitated the death of uninfected cells when a specific drug was introduced, effectively spreading the effects of the virus over longer distances in tumors. This insight is important because it reveals a new way to use these connections to enhance cancer treatment by making therapies more effective at reaching all cancer cells.
Who this helps: This helps cancer patients by improving treatment methods and potentially increasing the effectiveness of therapies.
Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis.
2015
Surgery
Eveno C, Mojica K, Ady JW, Thorek DL, Longo V +8 more
Plain English This study looked at a new gene therapy using a modified virus called GLV-1h153 to treat a severe form of colorectal cancer known as peritoneal carcinomatosis. The researchers found that this virus effectively killed cancer cells and significantly reduced tumor size in mice, with a viral load increase of more than 2.35 times over four days. This is important because it could lead to better treatment options and ways to monitor how well the therapy is working.
Who this helps: Patients with advanced colorectal cancer and their doctors.
Ady JW, Johnsen C, Mojica K, Heffner J, Love D +6 more
Plain English This study looked at a new treatment for liver cancer (hepatocellular carcinoma, or HCC) using a modified virus called GLV-2b372. The researchers found that this virus could kill 70% of liver cancer cells within five days and help shrink tumors in mice by 50%, while untreated tumors grew by 400%. This treatment could be an important option for patients with advanced liver cancer who have limited choices.
Who this helps: Patients with advanced liver cancer.
Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.
2015
Cancer gene therapy
Pugalenthi A, Mojica K, Ady JW, Johnsen C, Love D +4 more
Plain English Researchers studied a new treatment called GLV-1h68, a specially modified virus, to see how well it can fight advanced cholangiocarcinoma (a type of liver cancer). They found that this virus effectively killed cancer cells in three different cancer cell lines and significantly reduced tumor growth in mice after just one treatment, with no major side effects. This is important because it offers a potential new option for patients with advanced-stage cholangiocarcinoma who currently have very limited treatment choices.
Who this helps: This helps patients with advanced cholangiocarcinoma.
Oncolytic viral therapy for pancreatic cancer: current research and future directions.
2014
Oncolytic virotherapy
Ady JW, Heffner J, Klein E, Fong Y
Plain English Researchers are studying a new treatment called oncolytic viral therapy for pancreatic cancer, which involves using specially modified viruses that can attack cancer cells. Current treatments haven't improved the 5-year survival rate significantly, but this new approach offers hope. They are making progress in understanding how these viruses can be used to specifically target and destroy cancer cells, potentially giving patients better treatment options.
Who this helps: This helps patients with pancreatic cancer.
Ady JW, Heffner J, Mojica K, Johnsen C, Belin LJ +8 more
Plain English This study looked at a new cancer treatment using a modified virus called GLV-1h68, which can specifically target and kill liver cancer cells that do not respond to the standard drug sorafenib. Researchers found that GLV-1h68 was effective in killing cancer cells from four different liver cancer lines, regardless of their resistance to sorafenib. This research matters because it shows promise for treating patients with advanced liver cancer who have not benefited from existing therapies.
Who this helps: This helps patients with sorafenib-resistant liver cancer.
Intercellular communication in malignant pleural mesothelioma: properties of tunneling nanotubes.
2014
Frontiers in physiology
Ady JW, Desir S, Thayanithy V, Vogel RI, Moreira AL +5 more
Plain English The research focused on a type of aggressive lung cancer called malignant pleural mesothelioma and looked at how cancer cells communicate with each other through structures called tunneling nanotubes (TnTs). The study found that these nanotubes are present in mesothelioma cells and facilitate communication between them, with varying numbers of TnTs observed in different cancer cell types. Understanding TnTs is important because they may contribute to how these cancer cells spread, which could lead to better treatment strategies.
Who this helps: This helps patients with malignant pleural mesothelioma by potentially leading to improved therapies.
Imaging for infection: from visualization of inflammation to visualization of microbes.
2014
Surgical infections
Ady J, Fong Y
Plain English This study reviewed how doctors use advanced imaging techniques to detect and treat infections. Traditional methods like CT scans are commonly used to find sources of infection, while new imaging techniques can directly visualize bacteria and viruses, improving the accuracy of diagnosis. For instance, newer methods can accurately identify infection sites in animals, but these techniques are not yet widely used in human medicine.
Who this helps: This benefits patients with infections by enabling more accurate and timely diagnoses.
An oncolytic vaccinia virus expressing the human sodium iodine symporter prolongs survival and facilitates SPECT/CT imaging in an orthotopic model of malignant pleural mesothelioma.
2013
Surgery
Belin LJ, Ady JW, Lewis C, Marano D, Gholami S +7 more
Plain English This study looked at a treatment method using a modified vaccinia virus that carries a human gene, aiming to fight malignant pleural mesothelioma (a type of cancer). The researchers found that this virus could significantly reduce tumors and improve survival in mice with this cancer; specifically, they reported more than a 2.5-fold increase in the virus over four days and a notable drop in tumor size one week after treatment. This matters because it shows a potential new way to both treat this aggressive cancer and allow doctors to monitor the therapy's effectiveness with imaging technology.
Who this helps: Patients with malignant pleural mesothelioma.